Larotrectinib imaging response in low-grade glioma

Pediatr Blood Cancer. 2020 Jan;67(1):e28002. doi: 10.1002/pbc.28002. Epub 2019 Sep 22.

Authors

Andrew W Walter¹, Vinay V R Kandula¹, Nidhi Shah²

Affiliations

¹ Divisions of Pediatric Hematology/Oncology, Department of Imaging, A. I. duPont Hospital for Children, Wilmington, Delaware, USA.
² Pediatric Hematology/Oncology, Penn State College of Medicine, Hershey, Pennsylvania, USA.

PMID: 31544356
DOI: 10.1002/pbc.28002

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Brain Neoplasms / drug therapy
Brain Neoplasms / pathology*
Child, Preschool
Glioma / drug therapy
Glioma / pathology*
Humans
Magnetic Resonance Imaging / methods*
Male
Neoplasm Grading
Neuroimaging / methods*
Pyrazoles / therapeutic use*
Pyrimidines / therapeutic use*
Treatment Outcome

Substances

Pyrazoles
Pyrimidines
larotrectinib